Skip to content

A Clinical Investigation of the ClarVista HARMONI(Trademark) Modular Intraocular Lens Implant during Cataract Surgery

A Prospective, Multi-Center, Feasibility Trial of the ClarVista HARMONI (Trademark) Modular Intraocular Lens System for the treatment of Aphakia following Cataract Surgery

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12615000892516
Enrollment
200
Registered
2015-08-26
Start date
2015-09-14
Completion date
2015-12-31
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The HARMONI(Trademark) Modular Intraocular Lens Implant System is an implantable artificial lens used to replace the natural lens that has been surgically removed as part of cataract surgery. The study lens is unlike a standard lens which is a single piece. The study lens has a base component and an optic component. The removable optic component allows optic exchange after the primary surgery to adjust the patient's visual function. The purpose of this study is to demonstrate the feasibility of HARMONI(Trademark) IOL (HMIOL) implantation and assembly in subjects undergoing cataract surgery. It also aims to demonstrate the feasibility of the HMIOL optic component exchange procedure (performed 3 months following primary cataract extraction)

Interventions

The surgery involves the implantation of an artificial lens inside the eye that replaces the focusing power of the natural lens that has surgically removed as part of cataract surgery. The study device (HARMONI MODULAR Intraocular Lens Implant System) includes a base component and an optic component which allows optic exchange after the primary surgical procedure. A standard implant is a single piece (no components). This implantation of the study device occurs in one eye while the other eye re

The surgery involves the implantation of an artificial lens inside the eye that replaces the focusing power of the natural lens that has surgically removed as part of cataract surgery. The study device (HARMONI MODULAR Intraocular Lens Implant System) includes a base component and an optic component which allows optic exchange after the primary surgical procedure. A standard implant is a single piece (no components). This implantation of the study device occurs in one eye while the other eye receives a commercially available artificial lens. The primary implantation procedure takes about 5 minutes but the entire cataract procedure takes about 30 minutes, typically performed under topical or local anesthesia by an ophthalmic surgeon. An optic exchange may be performed 3 months after the primary surgery to adjust the subject's visual function. This procedure takes about 15 minutes under the same anesthetic method and also performed by an ophthalmic surgeon. The implant package label will be collected on the CRF.

Sponsors

ClarVista Medical
Lead SponsorCommercial sector/Industry

Study design

Allocation
Non-randomised trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
22 Years to No maximum
Healthy volunteers
No

Inclusion criteria

bilateral cataract, candidate for cataract surgery

Exclusion criteria

eye or systemic diseases that can influence study outcomes

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026